Modulators Of Dnm2 Expression Freier; Susan M. ; et al. [Ionis Pharmaceuticals, Inc.]
![Modulators Of Dnm2 Expression Freier; Susan M. ; et al. [Ionis Pharmaceuticals, Inc.]](https://uspto.report/patent/app/20190241896/US20190241896A1-20190808-C00006.png)
U.S. Patent Application 20190241896 for Modulators Of Dnm2 Expression
SEC Filing Sarepta Therapeutics, Inc.
Modulators Of Dnm2 Expression Freier; Susan M. ; et al. [Ionis Pharmaceuticals, Inc.]
IJMS, Free Full-Text
US20050245475A1 - Functional and hyperfunctional siRNA directed against Bcl-2 - Google Patents
PDF) Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
Modulators Of Dnm2 Expression Freier; Susan M. ; et al. [Ionis Pharmaceuticals, Inc.]
IJMS, Free Full-Text
US20200392510A1 - Modulators of dnm2 expression - Google Patents
Shuling GUO, Director, Doctor of Philosophy, Ionis Pharmaceuticals, Carlsbad, Antisense Drug Discovery
WO2017053722A1 - Modulators of kras expression - Google Patents
Surface-induced dissociation of protein complexes on a cyclic ion mobility spectrometer - Analyst (RSC Publishing) DOI:10.1039/D1AN01407B
ES2380354T5 - 2'-O, 4'-C-methylene bicyclonucleosides - Google Patents
